E Fund Management’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$86.6K	Buy	+35,492	New	+$71.1K	﹤0.01%	476
2025 Q1	–	Sell	-25,992	Closed	-$55.4K	–	400
2024 Q4	$55.4K	Buy	25,992 +5,629	+28%	+$13.9K	﹤0.01%	387
2024 Q3	$57K	Sell	20,363 -4,970	-20%	-$13.2K	﹤0.01%	349
2024 Q2	$59K	Sell	25,333 -11,797	-32%	-$34.8K	﹤0.01%	314
2024 Q1	$166K	Buy	+37,130	New	+$155K	0.01%	356
2023 Q4	–	Sell	-40,325	Closed	-$128K	–	309
2023 Q3	$128K	Sell	40,325 -736	-2%	-$3.23K	0.01%	274
2023 Q2	$204K	Buy	41,061 +2,624	+7%	+$14.2K	0.02%	277
2023 Q1	$190K	Sell	38,437 -1,208	-3%	-$7.75K	0.01%	305
2022 Q4	$249K	Buy	39,645 +8,037	+25%	+$74.4K	0.02%	260
2022 Q3	$341K	Buy	31,608 +6,602	+26%	+$89.7K	0.03%	215
2022 Q2	$285K	Sell	25,006 -3,309	-12%	-$29.4K	0.03%	242
2022 Q1	$258K	Buy	+28,315	New	+$295K	0.01%	248